Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses

Wang, S. V., Schneeweiß, S., Initiative, R.-D., Franklin, J. M., Desai, R. J., Feldman, W. B., Garry, E. M., Glynn, R. J., Lin, K. J., Paik, J. M., et al. (2023) · JAMA · doi:10.1001/jama.2023.4221 · Cited by 424 · see citing works

Neutralizing Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 in Coronavirus Disease 2019 Inpatients and Convalescent Patients

Wang, X., Guo, X., Xin, Q., Pan, Y., Hu, Y., Li, J., Chu, Y., Feng, Y., & Wang, Q. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa721 · Cited by 358 · see citing works

Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy

Zhang, Q., Xiang, R., Huo, S., Zhou, Y., Jiang, S., Wang, Q., & Yu, F. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00653-w · Cited by 341 · see citing works

Covid-19 vaccines production and societal immunization under the serendipity-mindsponge-3D knowledge management theory and conceptual framework

Vuong, Q., Le, T.-T., La, V., Huyền, N. T. T., Ho, M., Khuc, Q. V., & Nguyen, M. (2022) · Humanities and Social Sciences Communications · doi:10.1057/s41599-022-01034-6 · Cited by 339 · see citing works

Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019

Rajter, J. C., Sherman, M. S., Fatteh, N., Vogel, F., Sacks, J., & Rajter, J.-J. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.10.009 · Cited by 317 · see citing works

Potential impact of seasonal forcing on a SARS-CoV-2 pandemic

Neher, R. A., Dyrdak, R., Druelle, V., Hodcroft, E. B., & Albert, J. (2020) · Swiss Medical Weekly · doi:10.4414/smw.2020.20224 · Cited by 279 · see citing works

Misinformation about COVID-19: evidence for differential latent profiles and a strong association with trust in science

Agley, J. D., & Xiao, Y. (2021) · BMC Public Health · doi:10.1186/s12889-020-10103-x · Cited by 266 · see citing works

Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis

Kim, M. S., An, M. H., Kim, W. J., & Hwang, T.-H. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003501 · Cited by 251 · see citing works

COVID-SCORE: a global survey to assess public perceptions of government responses to COVID-19 (COVID-SCORE-10)

Lazarus, J. V., Ratzan, S., Palayew, A., Billari, F. C., Binagwaho, A., Kimball, S., Larson, H. J., Melegaro, A., Rabin, K., White, T. M., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0240011 · Cited by 232 · see citing works

Clinical Characterization and Prediction of Clinical Severity of SARS-CoV-2 Infection Among US Adults Using Data From the US National COVID Cohort Collaborative

Bennett, T. D., Moffitt, R. A., Hajagos, J., Amor, B., Anand, A., Bissell, M. M., Bradwell, K. R., Bremer, C., Byrd, J. B., Denham, A., et al. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.16901 · Cited by 230 · see citing works

How COVID-19 has fundamentally changed clinical research in global health

Park, J., Mogg, R., Smith, G. E., Nakimuli‐Mpungu, E., Jehan, F., Rayner, C. R., Condo, J. U., Decloedt, E. H., Nachega, J. B., Reis, G., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30542-8 · Cited by 220 · see citing works

Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19

Singh, B., Ryan, H., Kredo, T., Chaplin, M., & Fletcher, T. E. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013587.pub2 · Cited by 218 · see citing works

A double-edged sword—telemedicine for maternal care during COVID-19: findings from a global mixed-methods study of healthcare providers

Galle, A., Semaan, A. T., Huysmans, E., Audet, C., Asefa, A., Delvaux, T., Afolabi, B. B., Ayadi, A. M. E., & Beňová, L. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2020-004575 · Cited by 193 · see citing works

False individual patient data and zombie randomised controlled trials submitted to <i>Anaesthesia</i>

Carlisle, J. B. (2021) · Anaesthesia · doi:10.1111/anae.15263 · Cited by 173 · see citing works

The carnage of substandard research during the COVID-19 pandemic: a call for quality

Bramstedt, K. A. (2020) · Journal of Medical Ethics · doi:10.1136/medethics-2020-106494 · Cited by 170 · see citing works

COVID-19: a review

Papadopoulos, C., Chong, S. J. K., & Jaunoo, S. (2020) · IJS Short Reports · doi:10.1097/sr9.0000000000000007 · Cited by 165 · see citing works

SARS-CoV-2: characteristics and current advances in research

Yang, Y., Xiao, Z., Ye, K., He, X., Sun, B., Qin, Z., Yu, J., Yao, J., Wu, Q., Bao, Z., et al. (2020) · Virology Journal · doi:10.1186/s12985-020-01369-z · Cited by 162 · see citing works

Malaria and COVID-19: unmasking their ties

Hussein, M. I. H., Albashir, A. A. D., Elawad, O. A. M. A., & Homeida, A. (2020) · Malaria Journal · doi:10.1186/s12936-020-03541-w · Cited by 156 · see citing works

High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors

Zhao, Y., Du, X., Duan, Y., Pan, X., Sun, Y., You, T., Han, L., Jin, Z., Shang, W., Yu, J., et al. (2021) · Protein & Cell · doi:10.1007/s13238-021-00836-9 · Cited by 155 · see citing works

Natural history of COVID-19 and therapeutic options

Gautret, P., Million, M., Jarrot, P., Camoin‐Jau, L., Colson, P., Fenollar, F., Léone, M., Scola, B. L., Devaux, C. A., Gaubert, J. Y., et al. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2021.1847640 · Cited by 151 · see citing works

COVID-19 and the Kidneys: An Update

Benedetti, C., Waldman, M. A., Zaza, G., Riella, L. V., & Cravedi, P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00423 · Cited by 142 · see citing works

Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study

Rivera, D. R. R., Peters, S., Panagiotou, O. A., Shah, D. P., Kuderer, N. M., Hsu, C., Rubinstein, S. M., Lee, B. J., Choueiri, T. K., Lopes, G. D. L., Jr., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0941 · Cited by 134 · see citing works

Chloroquine and Hydroxychloroquine for the Treatment of COVID-19: a Systematic Review and Meta-analysis

Elavarasi, A., Prasad, M., Seth, T., Sahoo, R. K., Madan, K., Nischal, N., Soneja, M., Sharma, A., Maulik, S. K., Shalimar, S., et al. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06146-w · Cited by 121 · see citing works

Health informatics and EHR to support clinical research in the COVID-19 pandemic: an overview

Dagliati, A., Malovini, A. L., Tibollo, V., & Bellazzi, R. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa418 · Cited by 120 · see citing works

Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future

Godman, B., Haque, M., Islam, S., Iqbal, S., Urmi, U. L., Kamal, Z. M., Shuvo, S. N., Rahman, A., Kamal, M., Haque, M., et al. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.585832 · Cited by 114 · see citing works

Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019

Bansal, P., Goyal, A., Cusick, A. S., Lahan, S., Dhaliwal, H. S., Bhyan, P., Bhattad, P. B., Aslam, F., Ranka, S., Dalia, T., et al. (2020) · Annals of Medicine · doi:10.1080/07853890.2020.1839959 · Cited by 114 · see citing works

Forensic and Pharmaceutical Risks in the Organization of Pharmacotherapy of Covid, Post-Covid and Long-Covid Disorders. COVID-19 and Vaccination Practice Standards.

Шаповалова, В. (2022) · SSP Modern Pharmacy and Medicine · doi:10.53933/sspmpm.v2i4.69 · Cited by 112 · see citing works

COVID-19 outpatients: early risk-stratified treatment with zinc plus low-dose hydroxychloroquine and azithromycin: a retrospective case series study

Derwand, R., Scholz, M., & Zelenko, V. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.106214 · Cited by 111 · see citing works

Is hydroxychloroquine beneficial for COVID-19 patients?

Li, X., Wang, Y., Agostinis, P., Rabson, A. B., Melino, G., Carafoli, E., Shi, Y., & Sun, E. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2721-8 · Cited by 108 · see citing works

Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

Castelnuovo, A. F. D., Costanzo, S., Antinori, A., Berselli, N., Blandi, L., Bruno, R., Cauda, R., Guaraldi, G., Menicanti, L., My, I., et al. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.08.019 · Cited by 108 · see citing works

Evaluating the Impact of COVID-19 on Society, Environment, Economy, and Education

Kumar, V., Alshazly, H. A., Idris, S. A., & Bourouis, S. (2021) · Sustainability · doi:10.3390/su132413642 · Cited by 104 · see citing works

Cuidar al que cuida: el impacto emocional de la epidemia de coronavirus en las enfermeras y otros profesionales de la salud

Bueno‐Ferrán, M., & Barrientos‐Trigo, S. (2020) · Enfermería Clínica · doi:10.1016/j.enfcli.2020.05.006 · Cited by 103 · see citing works

COVID-19: Review of a 21st Century Pandemic from Etiology to Neuro-psychiatric Implications

Yamamoto, V., Bolanos, J. F., Fiallos, J., Strand, S. E., Morris, K., Shahrokhinia, S., Cushing, T. R., Hopp, L., Tiwari, A., Hariri, R., et al. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200831 · Cited by 100 · see citing works

Immunopathology of SARS-CoV-2 Infection: Immune Cells and Mediators, Prognostic Factors, and Immune-Therapeutic Implications

Allegra, A., Gioacchino, M. D., Tonacci, A., Musolino, C., & Gangemi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134782 · Cited by 97 · see citing works

Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing

El‐Malah, A., Gineinah, M. M., Deb, P. K., Khayyat, A. N., Bansal, M., Venugopala, K. N., & Aljahdali, A. S. (2022) · Pharmaceuticals · doi:10.3390/ph15070827 · Cited by 97 · see citing works

Evaluation of Data Sharing After Implementation of the International Committee of Medical Journal Editors Data Sharing Statement Requirement

Danchev, V., Min, Y., Borghi, J., Baiocchi, M., & Ioannidis, J. P. A. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.33972 · Cited by 94 · see citing works

[Comment] The COVID‑19 pandemic as a scientific and social challenge in the 21st century

Zoumpourlis, V., Goulielmaki, M., Rizos, E. N., Baliou, S., & Spandidos, D. A. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11393 · Cited by 91 · see citing works

Impacts and interactions of COVID-19 response involvement, health-related behaviours, health literacy on anxiety, depression and health-related quality of life among healthcare workers: a cross-sectional study

Tran, T. V., Nguyen, H. C., Pham, L. V., Nguyen, M. H., Nguyen, H. C., Ha, T. H., Phan, D. T., Dao, H. K., Nguyen, P. B., Trinh, M. V., et al. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-041394 · Cited by 90 · see citing works

COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers

Hultcrantz, M. L., Richter, J. R., Rosenbaum, C. A., Patel, D., Smith, E. L., Korde, N., Lu, S. X., Mailankody, S., Shah, U. A., Lesokhin, A. M., et al. (2020) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0102 · Cited by 89 · see citing works

Acute chloroquine and hydroxychloroquine toxicity: A review for emergency clinicians

Porta, A. D., Bornstein, K., Coye, A., Montrief, T., Long, B., & Parris, M. A. (2020) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2020.07.030 · Cited by 88 · see citing works

Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study

Zdravković, M., Berger‐Estilita, J., Zdravković, B., & Berger, D. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241826 · Cited by 86 · see citing works

COVID-19 drug discovery and treatment options

Chan, J. F., Yuan, S., Chu, H., Sridhar, S., & Yuen, K. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01036-y · Cited by 87 · see citing works

The “Infodemic” of COVID‐19

Solomon, D. H., Bucala, R., Kaplan, M. J., & Nigrovic, P. A. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41468 · Cited by 86 · see citing works

A multicenter, randomized, open-label, controlled trial to evaluate the efficacy and tolerability of hydroxychloroquine and a retrospective study in adult patients with mild to moderate coronavirus disease 2019 (COVID-19)

Chen, C., Lin, Y., Chen, T., Tseng, T.-Y., Wong, H.-L., Kuo, C.-Y., Lin, W.-P., Huang, S.-R., Wang, W., Liao, J.-H., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242763 · Cited by 79 · see citing works

Hydroxychloroquine prophylaxis and treatment is ineffective in macaque and hamster SARS-CoV-2 disease models

Rosenke, K., Jarvis, M. A., Feldmann, F., Schwarz, B. H., Okumura, A., Lovaglio, J., Saturday, G. A., Hanley, P. W., Meade-White, K. D., Williamson, B. N., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.143174 · Cited by 77 · see citing works

Identifying factors contributing to increased susceptibility to COVID-19 risk: a systematic review of Mendelian randomization studies

Luo, S., Liang, Y., Wong, T. H. T., Schooling, C. M., & Yeung, S. L. A. (2022) · International Journal of Epidemiology · doi:10.1093/ije/dyac076 · Cited by 76 · see citing works

Characteristics and Management of Children With COVID-19 in Turkey

Yayla, B. C. C., Özsürekçi, Y., Aykaç, K., Oygar, P. D., Gürlevik, S. L., İlbay, S., Kukul, M. G., Karahan, S., Cengiz, A. B., & Ceyhan, M. (2020) · Balkan Medical Journal · doi:10.4274/balkanmedj.galenos.2020.2020.7.52 · Cited by 73 · see citing works

Journal policies and editors’ opinions on peer review

Hamilton, D. G., Fraser, H. S., Hoekstra, R., & Fidler, F. M. (2020) · eLife · doi:10.7554/elife.62529 · Cited by 73 · see citing works

COVID-19 treatment options: a difficult journey between failed attempts and experimental drugs

Bartoli, A., Gabrielli, F., Alicandro, T., Nascimbeni, F., & Andreoné, P. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02569-9 · Cited by 73 · see citing works

Antirheumatic Disease Therapies for the Treatment of COVID‐19: A Systematic Review and Meta‐Analysis

Putman, M., Chock, Y. P. E., Tam, H. H. Y., Kim, A. H. J., Sattui, S. E., Berenbaum, F., Danila, M. I., Korsten, P., Sánchez-Álvarez, C., Sparks, J. A., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41469 · Cited by 71 · see citing works

Proliferation of Papers and Preprints During the Coronavirus Disease 2019 Pandemic: Progress or Problems With Peer Review?

Vlasschaert, C., Topf, J. M., & Hiremath, S. S. (2020) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2020.08.003 · Cited by 70 · see citing works

Reproducible Research: A Retrospective

Peng, R. D., & Hicks, S. C. (2021) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-012420-105110 · Cited by 70 · see citing works

O uso político da cloroquina: COVID-19, negacionismo e neoliberalismo / The political use of chloroquine: COVID-19, denialism and neoliberalism

Caponi, S. N., Brzozowski, F. S., Hellmann, F., & Bittencourt, S. C. (2021) · Revista Brasileira de Sociologia - RBS · doi:10.20336/rbs.774 · Cited by 68 · see citing works

Heterocyclic compounds as antiviral drugs: Synthesis, structure–activity relationship and traditional applications

dos Santos, G. C., Martins, L. M., Bregadiolli, B. A., Moreno, V. F., da Silva‐Filho, L. C., & Silva, B. (2021) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.4349 · Cited by 68 · see citing works

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study

Prats-Uribe, A., Sena, A. G., Lai, L. Y. H., Ahmed, W.-U.-R., Alghoul, H., Alser, O., Alshammari, T. M., Areia, C., Carter, W., Casajust, P., et al. (2021) · BMJ · doi:10.1136/bmj.n1038 · Cited by 68 · see citing works

Pandemics and Traditional Plant-Based Remedies. A Historical-Botanical Review in the Era of COVID19

Garcia, S. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2020.571042 · Cited by 67 · see citing works

Swinging the pendulum: lessons learned from public discourse concerning hydroxychloroquine and COVID-19

Sattui, S. E., Liew, J. W., Graef, E. R., Coler-Reilly, A. L. G., Berenbaum, F., Duarte‐García, A., Harrison, C., Konig, M. F., Korsten, P., Putman, M., et al. (2020) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2020.1792778 · Cited by 66 · see citing works

Availability and price changes of potential medicines and equipment for the prevention and treatment of COVID-19 among pharmacy and drug stores in Bangladesh; findings and implications

Haque, M., Islam, S., Iqbal, S., Urmi, U., Kamal, Z., Rahman, A., Kamal, M., Haque, M., Jahan, I., Islam, Z., et al. (2020) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v19i0.48106 · Cited by 58 · see citing works

Publication rate and citation counts for preprints released during the COVID-19 pandemic: the good, the bad and the ugly

Añazco, D., Nicolalde, B., Espinosa, I., Camacho, J., Mushtaq, M., Gimenez, J., & Teran, E. (2021) · PeerJ · doi:10.7717/peerj.10927 · Cited by 63 · see citing works

Challenges and Lessons Learned From COVID-19 Trials: Should We Be Doing Clinical Trials Differently?

Janiaud, P., Hemkens, L. G., & Ioannidis, J. P. A. (2021) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2021.05.009 · Cited by 63 · see citing works

Better engagement, better evidence: working in partnership with patients, the public, and communities in clinical trials with involvement and good participatory practice

Gobat, N., Slack, C., Hannah, S., Salzwedel, J., Bladon, G., Burgos, J. G., Purvis, B., Molony-Oates, B., Siegfried, N., Cheah, P. Y., et al. (2025) · The Lancet Global Health · doi:10.1016/s2214-109x(24)00521-7 · Cited by 61 · see citing works

Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection

Palmeira, A., Sousa, E., Köseler, A., Sabırlı, R., Gören, T., Türkçüer, İ., Kurt, Ö., Pinto, M. M. M., & Vasconcelos, M. H. (2020) · Pharmaceuticals · doi:10.3390/ph13060132 · Cited by 61 · see citing works

The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example

Duchesneau, E. D., Jackson, B. E., Webster‐Clark, M., Lund, J. L., Reeder-Hayes, K. E., Nápoles, A. M., & Strassle, P. D. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-0495 · Cited by 61 · see citing works

Misleading Beyond Visual Tricks: How People Actually Lie with Charts

Lisnic, M., Polychronis, C., Lex, A., & Kogan, M. (2023) · CHI Conference on Human Factors in Computing Systems · doi:10.1145/3544548.3580910 · Cited by 60 · see citing works

Suggestions for a Covid-19 Post-Pandemic Research Agenda in Environmental Economics

Elliott, R., Schumacher, I., & Withagen, C. A. A. M. (2020) · Environmental and Resource Economics · doi:10.1007/s10640-020-00478-1 · Cited by 59 · see citing works

The Application of Single‐Cell RNA Sequencing in Vaccinology

Noé, A., Cargill, T. N., Nielsen, C. M., Russell, A. J. C., & Barnes, E. J. (2020) · Journal of Immunology Research · doi:10.1155/2020/8624963 · Cited by 58 · see citing works

Dynamics of cross-platform attention to retracted papers

Peng, H., Romero, D. M., & Horvát, E.-Á. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2119086119 · Cited by 57 · see citing works

Radiation Fractionation Schedules Published During the COVID-19 Pandemic: A Systematic Review of the Quality of Evidence and Recommendations for Future Development

Thomson, D. J., Yom, S. S., Saeed, H., Naqa, I. E., Ballas, L., Bentzen, S. M., Chao, S. T., Choudhury, A., Coles, C. E., Dover, L. L., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.06.054 · Cited by 57 · see citing works

Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa

Margolin, E., Burgers, W. A., Sturrock, E. D., Mendelson, M., Chapman, R. E., Douglass, N., Williamson, A., & Rybicki, E. P. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-020-00441-3 · Cited by 57 · see citing works

Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications

Haque, M., Kumar, S., Charan, J., Bhatt, R., Islam, S., Dutta, S., Abhayanand, J. P., Sharma, Y., Sefah, I. A., Kurdi, A. B., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.582154 · Cited by 56 · see citing works

Towards a Research Agenda for Promoting Responsible Research Practices

Tijdink, J. K., Horbach, S. P. J. M., Nuijten, M. B., & O’Neill, G. (2021) · Journal of Empirical Research on Human Research Ethics · doi:10.1177/15562646211018916 · Cited by 56 · see citing works

Back to WHAT? The role of research ethics in pandemic times

Solbakk, J. H., Bentzen, H. B., Holm, S., Heggestad, A. K. T., Hofmann, B., Robertsen, A., Alnæs, A. H., Cox, S., Pedersen, R., & Bernabe, R. (2020) · Medicine Health Care and Philosophy · doi:10.1007/s11019-020-09984-x · Cited by 55 · see citing works

The National COVID Cohort Collaborative: Clinical Characterization and Early Severity PredictionPreprint

Bennett, T. D., Moffitt, R. A., Hajagos, J., Amor, B., Anand, A., Bissell, M. M., Bradwell, K. R., Bremer, C., Byrd, J. B., Denham, A., et al. (2021) · medRxiv · doi:10.1101/2021.01.12.21249511 · Cited by 55 · see citing works

Issues for the management of people with diabetes and COVID-19 in ICU

Ceriello, A., Standl, E., Catrinoiu, D., Itzhak, B., Lalic, N. M., Rahelić, D., Schnell, O., Škrha, J., & Valensi, P. E. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01089-2 · Cited by 54 · see citing works

Review of adverse cutaneous reactions of pharmacologic interventions for COVID-19: A guide for the dermatologist

Martínez‐López, A., Cuenca‐Barrales, C., Montero‐Vílchez, T., Molina‐Leyva, A., & Arias‐Santiago, S. (2020) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2020.08.006 · Cited by 52 · see citing works

Inconsistent and incomplete retraction of published research: A cross-sectional study on Covid-19 retractions and recommendations to mitigate risks for research, policy and practice

Frampton, G. K., Woods, L., & Scott, D. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258935 · Cited by 53 · see citing works

Placental transfer and safety in pregnancy of medications under investigation to treat coronavirus disease 2019

Louchet, M., Sibiude, J., Peytavin, G., Picone, O., Tréluyer, J., & Mandelbrot, L. (2020) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2020.100159 · Cited by 52 · see citing works

Learning from a retraction

The Editors of the Lancet Group (2020) · The Lancet · doi:10.1016/s0140-6736(20)31958-9 · Cited by 50 · see citing works

Potential repurposed SARS-CoV-2 (COVID-19) infection drugs

Abuo‐Rahma, G. E. A., Mohamed, M. F. A., Ibrahim, T. S., Shoman, M. E., Samir, E., & El-Baky, R. M. A. (2020) · RSC Advances · doi:10.1039/d0ra05821a · Cited by 49 · see citing works

Prior diagnoses and medications as risk factors for COVID-19 in a Los Angeles Health SystemPreprint

Chang, T. S., Ding, Y., Freund, M. K., Johnson, R., Schwarz, T., Yabu, J. M., Hazlett, C. J., Chiang, J. N., Wulf, A., UCLA Health Data Mart Working Group, et al. (2020) · medRxiv · doi:10.1101/2020.07.03.20145581 · Cited by 49 · see citing works

Hydroxychloroquine for covid-19: the end of the line?

Mahase, E. (2020) · BMJ · doi:10.1136/bmj.m2378 · Cited by 48 · see citing works

Efficacy and Safety of Lopinavir/Ritonavir for Treatment of COVID-19: A Systematic Review and Meta-Analysis

Alhumaid, S., Mutair, A. S. A., Alawi, Z. A., Alhmeed, N., Zaidi, A. R. Z., & Tobaiqy, M. A. (2020) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed5040180 · Cited by 48 · see citing works

SARS-CoV-2 (COVID-19) in patients with some degree of immunosuppression

Cajamarca-Barón, J., Guavita-Navarro, D., Buitrago-Bohórquez, J., Gallego-Cardona, L., Navas, Á., Cubides, H. H., Arredondo, A. M., Escobar, A., & Rojas‐Villarraga, A. (2020) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2020.08.001 · Cited by 47 · see citing works

Real-world evidence and product development: Opportunities, challenges and risk mitigation

Naidoo, P., Bouharati, C., Rambiritch, V., Jose, N. C., Karamchand, S., CHILTON, R. J., & Leisegang, R. F. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-021-01851-w · Cited by 47 · see citing works

Severe airport sanitarian control could slow down the spreading of COVID-19 pandemics in Brazil

Ribeiro, S. P., Dáttilo, W., Silva, A. C. E., Reis, A. B., Goés‐Neto, A., Alcântara, L. C. J., Giovanetti, M., Coura‐Vital, W., Fernandes, G. W., & Azevedo, V. (2020) · PeerJ · doi:10.7717/peerj.9446 · Cited by 47 · see citing works

Science at Warp Speed: Medical Research, Publication, and Translation During the COVID-19 Pandemic

Lipworth, W. L., Gentgall, M., Kerridge, I., & Stewart, C. L. (2020) · Journal of Bioethical Inquiry · doi:10.1007/s11673-020-10013-y · Cited by 46 · see citing works

Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19

Hernández, A. V., Roman, Y. M., Pasupuleti, V., Barboza, J. J., & White, C. M. (2020) · Annals of Internal Medicine · doi:10.7326/l20-0945 · Cited by 46 · see citing works

Weighing the Benefits and Risks of Proliferating Observational Treatment Assessments

Califf, R. M., Hernandez, A. F., & Landray, M. (2020) · JAMA · doi:10.1001/jama.2020.13319 · Cited by 45 · see citing works

Beneficial Effect of Statins in COVID-19–Related Outcomes—Brief Report

Lee, H., Ahn, J., Park, J., Kang, C. K., Won, S., Kim, D. W., Park, J. H., Chung, K.-H., Joh, J.-S., Bang, J. H., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315551 · Cited by 45 · see citing works

COVID-19 Treatment Guidelines: Do They Really Reflect Best Medical Practices to Manage the Pandemic?

Jirjees, F., Saad, A. K., AlHano, Z., Hatahet, T., Al-Obaidi, H. J., & Bashi, Y. H. D. (2021) · Infectious Disease Reports · doi:10.3390/idr13020029 · Cited by 45 · see citing works

The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males

Croci, S., Venneri, M. A., Mantovani, S., Fallerini, C., Benetti, E., Picchiotti, N., Campolo, F., Imperatore, F., Palmieri, M., Daga, S., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1995152 · Cited by 46 · see citing works

Nanomedicine as a promising strategy for the theranostics of infectious diseases

Liu, H., Zhong, W., Zhang, X., Lin, D., & Wu, J. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb01316e · Cited by 44 · see citing works

Love thy neighbour? Allocating vaccines in a world of competing obligations

Ferguson, K. E., & Caplan, A. L. (2020) · Journal of Medical Ethics · doi:10.1136/medethics-2020-106887 · Cited by 44 · see citing works

HIPAA and the Leak of “Deidentified” EHR Data

Mandl, K. D., & Perakslis, E. D. (2021) · New England Journal of Medicine · doi:10.1056/nejmp2102616 · Cited by 44 · see citing works

Viral fibrotic scoring and drug screen based on MAPK activity uncovers EGFR as a key regulator of COVID-19 fibrosis

Vagapova, E. R., Lebedev, T. D., & Prassolov, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-90701-w · Cited by 42 · see citing works

Nanomedicines Targeting Respiratory Injuries for Pulmonary Disease Management

Liu, D., Long, M., Gao, L., Chen, Y., Fang, L., Shi, Y., & Gu, N. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202112258 · Cited by 42 · see citing works

Retraction in the era of COVID-19 and its influence on evidence-based medicine: is science in jeopardy?

Boschiero, M. N., Carvalho, T. A., & Marson, F. A. L. (2020) · Pulmonology · doi:10.1016/j.pulmoe.2020.10.011 · Cited by 42 · see citing works

Real‐World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID‐19

Franklin, J. M., Lin, K. J., Gatto, N. M., Rassen, J. A., Glynn, R. J., & Schneeweiß, S. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2185 · Cited by 41 · see citing works

On the Importance of Data Transparency

Callaghan, S. (2020) · Patterns · doi:10.1016/j.patter.2020.100070 · Cited by 6 · see citing works

News in Brief

Passi, G. R. (2020) · Indian Pediatrics · doi:10.1007/s13312-020-1908-5

Learning from a retraction

The Editors of the Lancet Group (2020) · The Lancet · doi:10.1016/s0140-6736(20)31958-9 · Cited by 50 · see citing works

Data from Mehra et al. (2020-05-29), "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis"

Mehra, M. R., Desai, S. S., Ruschitzka, F. T., & Patel, A. N. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.3870966

Zweifelhafte COVID-Studien – die Grenzen des Peer Reviews und der Nutzen von Twitter

Nößler, D., & Scherer, M. (2020) · EvidenzUpdate · doi:10.69156/pod.001/2020.06.00035